PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11051228-11	2000	Isotretinoin had a modest, transient effect on the serum PSA level in 4 of 11 (36%) patients with a rising serum PSA after radical prostatectomy.	Isotretinoin	0-12	kallikrein related peptidase 3	Homo sapiens	57-60	
11051228-0	2000	Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy.	Isotretinoin	10-30	kallikrein related peptidase 3	Homo sapiens	40-65	
11051228-11	2000	Isotretinoin had a modest, transient effect on the serum PSA level in 4 of 11 (36%) patients with a rising serum PSA after radical prostatectomy.	Isotretinoin	0-12	kallikrein related peptidase 3	Homo sapiens	113-116	
9815590-0	1997	Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen.	Isotretinoin	10-30	kallikrein related peptidase 3	Homo sapiens	112-137	
9815590-1	1997	The objective of this study was to test the hypothesis that 13-cis-retinoic acid (CRA) and alpha-interferon (IFN-alpha) have antitumor activity in patients with early recurrence of prostate cancer measured by rising prostate-specific antigen (PSA) after local therapy, and that this activity is associated with the increase of plasma transforming growth factor beta1 (TGF-beta1).	Isotretinoin	60-80	kallikrein related peptidase 3	Homo sapiens	216-247	
9815590-1	1997	The objective of this study was to test the hypothesis that 13-cis-retinoic acid (CRA) and alpha-interferon (IFN-alpha) have antitumor activity in patients with early recurrence of prostate cancer measured by rising prostate-specific antigen (PSA) after local therapy, and that this activity is associated with the increase of plasma transforming growth factor beta1 (TGF-beta1).	Isotretinoin	82-85	kallikrein related peptidase 3	Homo sapiens	216-247	
10604265-4	1999	Of several agents recently shown to reduce prostate-specific antigen levels in phase II studies, 13-cis-retinoic acid and interferon-alpha can reduce the expression of bcl-2 and overcome bcl-2-mediated resistance to paclitaxel in resistant cell lines.	Isotretinoin	97-117	kallikrein related peptidase 3	Homo sapiens	43-68	
7523313-3	1994	The present study was designed to elucidate the role of 13-cis-retinoic acid (RA) in regulation of PSA and the tumorigenic potential of the human prostate cancer cell line LNCaP.	Isotretinoin	56-76	kallikrein related peptidase 3	Homo sapiens	99-102	
7523313-3	1994	The present study was designed to elucidate the role of 13-cis-retinoic acid (RA) in regulation of PSA and the tumorigenic potential of the human prostate cancer cell line LNCaP.	Isotretinoin	78-80	kallikrein related peptidase 3	Homo sapiens	99-102